Cargando…

Association between Cannabinoid CB(1) Receptor Expression and Akt Signalling in Prostate Cancer

BACKGROUND: In prostate cancer, tumour expression of cannabinoid CB(1) receptors is associated with a poor prognosis. One explanation for this association comes from experiments with transfected astrocytoma cells, where a high CB receptor expression recruits the Akt signalling survival pathway. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cipriano, Mariateresa, Häggström, Jenny, Hammarsten, Peter, Fowler, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673925/
https://www.ncbi.nlm.nih.gov/pubmed/23755281
http://dx.doi.org/10.1371/journal.pone.0065798
_version_ 1782272301384859648
author Cipriano, Mariateresa
Häggström, Jenny
Hammarsten, Peter
Fowler, Christopher J.
author_facet Cipriano, Mariateresa
Häggström, Jenny
Hammarsten, Peter
Fowler, Christopher J.
author_sort Cipriano, Mariateresa
collection PubMed
description BACKGROUND: In prostate cancer, tumour expression of cannabinoid CB(1) receptors is associated with a poor prognosis. One explanation for this association comes from experiments with transfected astrocytoma cells, where a high CB receptor expression recruits the Akt signalling survival pathway. In the present study, we have investigated the association between CB(1) receptor expression and the Akt pathway in a well-characterised prostate cancer tissue microarray. METHODOLOGY/PRINCIPAL FINDINGS: Phosphorylated Akt immunoreactivity (pAkt-IR) scores were available in the database. CB(1) receptor immunoreactivity (CB(1)IR) was rescored from previously published data using the same scale as pAkt-IR. There was a highly significant correlation between CB(1)IR and pAkt-IR. Further, cases with high expression levels of both biomarkers were much more likely to have a more severe form of the disease at diagnosis than those with low expression levels. The two biomarkers had additive effects, rather than an interaction, upon disease-specific survival. CONCLUSIONS/SIGNIFICANCE: The present study provides data that is consistent with the hypothesis that at a high CB(1) receptor expression, the Akt signalling pathway becomes operative.
format Online
Article
Text
id pubmed-3673925
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36739252013-06-10 Association between Cannabinoid CB(1) Receptor Expression and Akt Signalling in Prostate Cancer Cipriano, Mariateresa Häggström, Jenny Hammarsten, Peter Fowler, Christopher J. PLoS One Research Article BACKGROUND: In prostate cancer, tumour expression of cannabinoid CB(1) receptors is associated with a poor prognosis. One explanation for this association comes from experiments with transfected astrocytoma cells, where a high CB receptor expression recruits the Akt signalling survival pathway. In the present study, we have investigated the association between CB(1) receptor expression and the Akt pathway in a well-characterised prostate cancer tissue microarray. METHODOLOGY/PRINCIPAL FINDINGS: Phosphorylated Akt immunoreactivity (pAkt-IR) scores were available in the database. CB(1) receptor immunoreactivity (CB(1)IR) was rescored from previously published data using the same scale as pAkt-IR. There was a highly significant correlation between CB(1)IR and pAkt-IR. Further, cases with high expression levels of both biomarkers were much more likely to have a more severe form of the disease at diagnosis than those with low expression levels. The two biomarkers had additive effects, rather than an interaction, upon disease-specific survival. CONCLUSIONS/SIGNIFICANCE: The present study provides data that is consistent with the hypothesis that at a high CB(1) receptor expression, the Akt signalling pathway becomes operative. Public Library of Science 2013-06-05 /pmc/articles/PMC3673925/ /pubmed/23755281 http://dx.doi.org/10.1371/journal.pone.0065798 Text en © 2013 Cipriano et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Cipriano, Mariateresa
Häggström, Jenny
Hammarsten, Peter
Fowler, Christopher J.
Association between Cannabinoid CB(1) Receptor Expression and Akt Signalling in Prostate Cancer
title Association between Cannabinoid CB(1) Receptor Expression and Akt Signalling in Prostate Cancer
title_full Association between Cannabinoid CB(1) Receptor Expression and Akt Signalling in Prostate Cancer
title_fullStr Association between Cannabinoid CB(1) Receptor Expression and Akt Signalling in Prostate Cancer
title_full_unstemmed Association between Cannabinoid CB(1) Receptor Expression and Akt Signalling in Prostate Cancer
title_short Association between Cannabinoid CB(1) Receptor Expression and Akt Signalling in Prostate Cancer
title_sort association between cannabinoid cb(1) receptor expression and akt signalling in prostate cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673925/
https://www.ncbi.nlm.nih.gov/pubmed/23755281
http://dx.doi.org/10.1371/journal.pone.0065798
work_keys_str_mv AT ciprianomariateresa associationbetweencannabinoidcb1receptorexpressionandaktsignallinginprostatecancer
AT haggstromjenny associationbetweencannabinoidcb1receptorexpressionandaktsignallinginprostatecancer
AT hammarstenpeter associationbetweencannabinoidcb1receptorexpressionandaktsignallinginprostatecancer
AT fowlerchristopherj associationbetweencannabinoidcb1receptorexpressionandaktsignallinginprostatecancer